8.03 USD
↗ 0.06 (0.75%)AT CLOSE (11:59 AM EDT)
Kyntra Bio, Inc. Common Stock
KYNBNASDAQ • USD
8.04
↗ 0.01 (0.06%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
8.04
↗ 0.01 (0.06%)
Market: CLOSED
Kyntra Bio, Inc. Common Stock (KYNB) trades at $8.02 per share. Technical indicators currently signal "Buy". Key drivers include negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, KYNB appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Sep 14, 2026.
Open?$7.85
High?$8.06
Low?$7.79
Prev. Close?$7.97
Volume?23.8K
Avg. Volume?17.7K
VWAP?$7.90
Rel. Volume?1.34x
Bid / Ask
Bid?$6.68 × 100
Ask?$9.12 × 100
Spread?$2.44
Midpoint?$7.90
Valuation & Ratios
Market Cap?32.3M
Shares Out?4.0M
Float?3.9M
Float %?95.7%
P/E Ratio?0.18
P/B Ratio?-1.07
EPS?$45.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
Themes
Employees
34
Market Cap
32.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-11-14
Address
350 BAY STREET
SAN FRANCISCO, CA 94133
Phone: 415-978-1200
SAN FRANCISCO, CA 94133
Phone: 415-978-1200
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestModerate
Short % of Float?2.73%Low
Short Interest?105.8K
Days to Cover?4.6
Free Float3.9M
Avg Daily Volume22.8K
Settlement Date2026-08-31
Financial Health
Current Ratio?2.69Strong
Quick Ratio?2.59Strong
Cash Ratio?1.41Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score93/100
P/E?0.2CHEAP▾
Peers100
S&P97
P/B?-1.07CHEAP▾
S&P97
P/S?6.99FAIR▾
Peers100
S&P17
P/FCF?N/A▾
EV/EBITDA?0.4CHEAP▾
Peers100
S&P97
EV/Sales?-3.98CHEAP▾
S&P97
Returns & Efficiency
ROE?-607.7%WEAK▾
S&P3
ROA?181.2%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$-38062000
Enterprise Value?$-18372482
Fundamentals ratios updated end of day